José Luis Subiza Garrido-Lestache

15PUBLICATIONS
53CO-AUTHORS
AllergyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2026
Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoids in a Pre- and Co-Seasonal Treatment Regimen: An Exploratory Post Hoc Subgroup Analysis of Safety and Tolerability.

|Apr 30, 2026
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

|Dec 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar

|Sep 13, 2025
Peptides Derived from α-Tubulin Induce Functional T Regulatory Cells.

Tara Fiyouzi, Jose L Subiza, Esther M Lafuente

|Jan 08, 2025
Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells.

Eva Jiménez, Alberto Vázquez, Sara González

|Nov 09, 2024
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.

Ralph Mösges, Esther Raskopf, Ludger Klimek

Pageof 3

Frequent Collaborators

8 joint publications

Miguel Casanovas

5 joint publications

Sandra Del Pozo Collado

4 joint publications

Cengizhan Acikel

4 joint publications

Ralph Mösges